Form 4: Vita Coco CSO Sells Shares Under 10b5-1 Plan
Insider Transaction Report
Vita Coco's Chief Sales Officer, Charles van Es, sold 10,000 shares of common stock for approximately $400,020 after exercising stock options.
Summary
- Charles van Es, Chief Sales Officer of Vita Coco Company, Inc. (COCO), reported transactions on September 12, 2025.
- He exercised 10,000 non-qualified stock options at an exercise price of $10.178 per share.
- Concurrently, he sold 10,000 shares of common stock at a weighted average price of $40.002 per share, resulting in total proceeds of approximately $400,020.
- These transactions were executed pursuant to a pre-arranged Rule 10b5-1 trading plan.
- Following these transactions, Charles van Es directly beneficially owns 84,328 shares of common stock.
- He also holds various non-qualified stock options with exercise prices ranging from $10.178 to $33.36, subject to different vesting schedules and expiration dates.
Sentiment
Score: 6
Explanation: The filing reports a routine insider transaction where an officer exercised options and sold shares at a profit under a pre-arranged 10b5-1 plan. This is generally neutral for the company, but the profit realized by the officer reflects positively on the stock's performance relative to the option grant price.
Positives
- The officer realized a significant profit from exercising options and selling shares, indicating personal financial benefit.
- The sale was conducted under a pre-arranged Rule 10b5-1 trading plan, which suggests a planned, rather than opportunistic, transaction.
- The sale price of $40.002 per share is substantially higher than the exercise price of $10.178 per share, reflecting a positive stock performance for the options exercised.
Negatives
- An insider sale, even under a 10b5-1 plan, can sometimes be perceived as a reduction in insider confidence, though this is mitigated by the pre-planned nature of the transaction.
Future Outlook
NA
Industry Context
NA
Stakeholder Impact
- Shareholders: The sale by a Chief Sales Officer, while under a 10b5-1 plan, represents a reduction in insider ownership, which some investors may view with caution, though the volume is relatively small compared to the company's total outstanding shares.
- Reporting Person (Charles van Es): Realized a significant personal financial gain from the exercise and sale of stock options.
Key Dates
| Date | Description |
|---|---|
| 2022-11-27 | Start of vesting for a non-qualified stock option with an exercise price of $15, vesting in four equal annual installments. |
| 2024-03-10 | Start of vesting for a non-qualified stock option with an exercise price of $16.91, vesting in four equal annual installments. |
| 2025-03-04 | Start of vesting for a non-qualified stock option with an exercise price of $26.18, vesting in four equal annual installments. |
| 2025-03-04 | Start of vesting for a non-qualified stock option with an exercise price of $33.36, vesting in four equal annual installments. |
| 2025-08-15 | Start of vesting for a non-qualified stock option with an exercise price of $15.36, vesting in three equal annual installments. |
| 2025-09-12 | Date of option exercise and common stock sale by Charles van Es. |
| 2025-09-16 | Signature date of the reporting person's attorney-in-fact. |
| 2030-02-10 | Expiration date for a fully vested non-qualified stock option with an exercise price of $10.178. |
| 2031-01-11 | Expiration date for a fully vested non-qualified stock option with an exercise price of $10.178. |
| 2031-10-21 | Expiration date for a non-qualified stock option with an exercise price of $15. |
| 2032-08-15 | Expiration date for a non-qualified stock option with an exercise price of $15.36. |
| 2033-03-10 | Expiration date for a non-qualified stock option with an exercise price of $16.91. |
| 2034-03-04 | Expiration date for a non-qualified stock option with an exercise price of $26.18. |
| 2035-03-04 | Expiration date for a non-qualified stock option with an exercise price of $33.36. |
Keywords
Vita Coco, COCO, Insider Trading, Form 4, Stock Options, Rule 10b5-1, Charles van Es, Chief Sales Officer, Equity Sales
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.